5YJM
Human chymase in complex with 7-oxo-3-(phenoxyimino)-1,4-diazepane derivative
Summary for 5YJM
| Entry DOI | 10.2210/pdb5yjm/pdb |
| Descriptor | human chymase, 2-acetamido-2-deoxy-beta-D-glucopyranose, ZINC ION, ... (5 entities in total) |
| Functional Keywords | protease, inhibitor, complex, hydrolase |
| Biological source | Homo sapiens |
| Total number of polymer chains | 1 |
| Total formula weight | 26134.79 |
| Authors | Sugawara, H. (deposition date: 2017-10-11, release date: 2017-12-27, Last modification date: 2024-10-30) |
| Primary citation | Futamura-Takahashi, J.,Tanaka, T.,Sugawara, H.,Iwashita, S.,Imajo, S.,Oyama, Y.,Muto, T. Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors Bioorg. Med. Chem. Lett., 28:188-192, 2018 Cited by PubMed Abstract: Based on insight from the X-ray crystal structure of human chymase in complex with compound 1, a lactam carbonyl of the diazepane core was exchanged with O-substituted oxyimino group, leading to amidoxime derivatives. This modification resulted in highly potent chymase inhibitors, such as O-phenylamidoxime 5f. X-ray crystal structure analysis indicated that compound 5f induced movement of the Leu99 and Tyr94 side chains at the S2 site, and the increase in inhibitory activity of O-phenyl amidoxime derivatives suggested that the O-phenyl moiety interacted with the Tyr94 residue. Surface plasmon resonance experiments showed that compound 5f had slower association and dissociation kinetics and the calculated residence time of compound 5f to human chymase was extended compared to that of amide compound 1. PubMed: 29191554DOI: 10.1016/j.bmcl.2017.11.031 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report
